Dianthus Therapeutics Banner

Analyst Coverage

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Firm Analyst
Cantor Fitzgerald
Pete Stavropoulos, Ph.D.
Evercore ISI
Gavin Clark-Gartner
Guggenheim
Yatin Suneja
H.C. Wainwright & Co.
Swayampakula Ramakanth, Ph.D.
Jefferies
Maury Raycroft, Ph.D.
LifeSci Capital
Rami Katkhuda
Oppenheimer & Co.
Trevor Allred
Raymond James
Steven Seedhouse
Robert W. Baird & Co.
Joel Beatty, MD, CFA
Stifel
Alex Thompson
TD Cowen
Yaron Werber, M.D.
Wedbush
Laura Chico, Ph.D.

Dianthus Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Dianthus Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dianthus Therapeutics or its management. Dianthus Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.